Helicases as antiviral drug targets

Area of Science:

• Biochemistry
• Virology
• Drug Discovery

Background:

• Helicases are essential enzymes that unwind DNA/RNA using nucleoside triphosphate hydrolysis.
• These enzymes are vital for viral replication, making them attractive targets for antiviral drug development.
• Understanding viral helicase mechanisms is critical for designing effective therapeutics.

Purpose of the Study:

• To review methods for helicase identification, classification, and analysis.
• To provide an overview of helicases essential for human pathogenic virus replication.
• To highlight recent advancements in understanding viral helicase mechanisms and their therapeutic potential.

Main Methods:

• Review of literature on helicase identification, classification, and analysis techniques.
• Examination of structural and mechanistic studies of viral helicases, particularly from HSV and HCV.
• Analysis of the efficacy of helicase inhibitors in preclinical models.

Main Results:

• New analytical methods and atomic structures have improved understanding of helicase mechanisms.
• Herpes simplex virus (HSV) helicase-primase inhibitors (UL5, UL8, UL52) show promise in controlling HSV infection in animal models.
• Atomic structures and mechanistic studies of the Hepatitis C virus (HCV) NS3 helicase reveal unique characteristics compared to cellular proteins.

Conclusions:

• Advancements in helicase research, including structural biology and mechanistic studies, are crucial for antiviral drug discovery.
• Targeting viral helicases, such as those in HSV and HCV, holds significant potential for developing novel antiviral medications.
• Continued research into viral helicase function and inhibition is expected to lead to new treatments for viral infections.